ceftaroline

Brand: Teflaro

Prototype Drug
Drug Class: fifth-generation cephalosporin
Drug Family: antibiotic
Subclass: anti-MRSA cephalosporin
Organ Systems: infectious-disease

Mechanism of Action

Binds PBP2a in MRSA (and PBPs in susceptible organisms), overcoming the primary resistance mechanism of methicillin-resistant S. aureus; only FDA-approved beta-lactam with MRSA activity.

penicillin-binding protein 2a (PBP2a) in MRSA

Indications

  • community-acquired bacterial pneumonia (CABP)
  • acute bacterial skin and skin structure infections (ABSSSI) including MRSA

Contraindications

  • cephalosporin hypersensitivity

Adverse Effects

Common

  • diarrhea
  • nausea
  • rash
  • headache

Serious

  • C. difficile colitis
  • anaphylaxis
  • direct Coombs test positive (hemolytic anemia risk)
  • neutropenia

Pharmacokinetics (ADME)

Absorption IV only (prodrug ceftaroline fosamil activated to ceftaroline)
Distribution widely distributed; moderate protein binding
Metabolism prodrug hydrolyzed to active ceftaroline; renal clearance
Excretion renal (88% unchanged)
Half-life 2.6 hours
Onset immediate (IV)
Peak end of infusion
Duration 12 hours
Protein Binding 20%
Vd moderate

Drug Interactions

Drug / Agent Mechanism Severity
other beta-lactams theoretical additive effect; generally well tolerated in combination minor

Nursing Considerations

  1. Administer IV over 60 minutes; do not mix with other medications in the same IV line.
  2. Monitor CBC periodically; Coombs test seroconversion occurs in up to 10% of patients and can precede hemolytic anemia.
  3. Reduce dose in renal impairment (CrCl <50 mL/min).
  4. Monitor for signs of C. difficile infection: new or worsening diarrhea, abdominal cramping, fever.

Clinical Pearls

  • Ceftaroline is the only commercially available beta-lactam with activity against MRSA, achieved through its ability to bind PBP2a, the low-affinity PBP responsible for methicillin resistance.
  • A positive Coombs test during ceftaroline therapy is immunologically mediated but usually clinically insignificant; monitor CBC for frank hemolytic anemia.

Safety Profile

Pregnancy generally-safe
Lactation use-with-caution
Renal Adjustment Required
Hepatic Adjustment Not required
TDM Not required

Concordance Terms

Cross-referenced clinical concepts — click any term to see all content where it appears.